Share-based Payment Arrangement, Expense of Opus Genetics, Inc. from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Opus Genetics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • Opus Genetics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $816,000, a 5.2% increase year-over-year.
  • Opus Genetics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $3,420,000, a 4.3% increase year-over-year.
  • Opus Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $3,362,000, a 4.2% decline from 2023.
  • Opus Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3,510,000, a 94% increase from 2022.
  • Opus Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1,807,000, a 5.6% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Opus Genetics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,420,000 $816,000 +$40,000 +5.2% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $3,380,000 $896,000 +$90,000 +11% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $3,290,000 $913,000 -$72,000 -7.3% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $3,362,000 $795,000 +$84,000 +12% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $3,278,000 $776,000 +$203,000 +35% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $3,075,000 $806,000 -$616,000 -43% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $3,691,000 $985,000 +$181,000 +23% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $3,510,000 $711,000 +$287,000 +68% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $3,223,000 $573,000 +$80,000 +16% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $3,143,000 $1,422,000 +$977,000 +220% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $2,166,000 $804,000 +$359,000 +81% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $1,807,000 $424,000 -$55,000 -11% 01 Oct 2022 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q3 2022 $1,862,000 $493,000 +$15,000 +3.1% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $1,847,000 $445,000 -$18,000 -3.9% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $1,865,000 $445,000 -$49,000 -9.9% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $1,914,000 $479,000 -$34,000 -6.6% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,948,000 $478,000 -$138,000 -22% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $2,086,000 $463,000 +$147,000 +47% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $1,939,000 $494,000 +$433,000 +710% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $1,506,000 $513,000 +$584,348 01 Oct 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $921,652 $616,000 +$525,305 +579% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $396,347 $316,000 +$188,347 +148% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $208,000 $61,000 -$100,000 -62% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $308,000 $71,348 -$454,473 -119% 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $762,473 $90,695 -$190,787 -68% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q2 2019 $953,260 $127,653 -$139,498 -52% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $1,092,758 $161,000 -$135,577 -46% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $1,228,335 $383,125 +$128,964 +51% 01 Oct 2018 31 Dec 2018 10-K 21 Feb 2020 2019 FY
Q3 2018 $1,099,371 $281,482 +$53,868 +24% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $1,045,503 $267,151 -$20,914 -7.3% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $1,066,417 $296,577 +$22,250 +8.1% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $1,044,167 $254,161 -$91,738 -27% 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 $1,135,905 $227,614 -$141,788 -38% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018 2018 Q3
Q2 2017 $1,277,693 $288,065 -$63,111 -18% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2018 Q2
Q1 2017 $1,340,804 $274,327 -$68,684 -20% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q4 2016 $1,409,488 $345,899 +$77,888 +29% 01 Oct 2016 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q3 2016 $1,331,600 $369,402 +$144,086 +64% 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017 2017 Q3
Q2 2016 $1,187,514 $351,176 +$79,210 +29% 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2017 2017 Q2
Q1 2016 $1,108,304 $343,011 +$70,625 +26% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q4 2015 $1,037,679 $268,011 +$83,275 +45% 01 Oct 2015 31 Dec 2015 10-K 09 Mar 2018 2017 FY
Q3 2015 $954,404 $225,316 +$62,125 +38% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $892,279 $271,966 +$139,448 +105% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $752,831 $272,386 +$144,036 +112% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q4 2014 $608,795 $184,736 +$113,345 +159% 01 Oct 2014 31 Dec 2014 10-K 24 Feb 2017 2016 FY
Q3 2014 $495,450 $163,191 +$95,476 +141% 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015 2015 Q3
Q2 2014 $399,974 $132,518 +$78,147 +144% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $321,827 $128,350 -$243,601 -65% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q4 2013 $565,428 $71,391 +$42,941 +151% 01 Oct 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
Q3 2013 $522,487 $67,715 +$7,104 +12% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 $515,383 $54,371 +$3,619 +7.1% 01 Apr 2013 30 Jun 2013 10-Q 13 Aug 2014 2014 Q2
Q1 2013 $511,764 $371,951 +$280,777 +308% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q4 2012 $230,987 $28,450 01 Oct 2012 31 Dec 2012 10-K 21 Mar 2014 2013 FY
Q3 2012 $60,611 -$80,478 -57% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3
Q2 2012 $50,752 -$119,426 -70% 01 Apr 2012 30 Jun 2012 10-Q 12 Aug 2013 2013 Q2
Q1 2012 $91,174 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q3 2011 $141,089 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 $170,178 01 Apr 2011 30 Jun 2011 10-Q 08 Aug 2012 2012 Q2

Opus Genetics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,362,000 -$148,000 -4.2% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $3,510,000 +$1,703,000 +94% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $1,807,000 -$107,000 -5.6% 01 Jan 2022 31 Dec 2022 10-K 08 Mar 2024 2023 FY
2021 $1,914,000 +$408,000 +27% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $1,506,000 +$1,198,000 +389% 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2019 $308,000 -$920,335 -75% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $1,228,335 +$184,168 +18% 01 Jan 2018 31 Dec 2018 10-K 21 Feb 2020 2019 FY
2017 $1,044,167 -$365,321 -26% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 $1,409,488 +$371,809 +36% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2018 2017 FY
2015 $1,037,679 +$428,884 +70% 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2018 2017 FY
2014 $608,795 +$43,367 +7.7% 01 Jan 2014 31 Dec 2014 10-K 24 Feb 2017 2016 FY
2013 $565,428 +$334,441 +145% 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
2012 $230,987 -$407,620 -64% 01 Jan 2012 31 Dec 2012 10-K 21 Mar 2014 2013 FY
2011 $638,607 01 Jan 2011 31 Dec 2011 10-K 22 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.